COVID 19: Diabetes and Obesity API-ICP Recommendations

J Assoc Physicians India. 2020 May;68(5):42-44.

Abstract

Diabetes and Obesity are major risk factors which confer vulnerability to Covid 19 . Diabetes has immune defects which makes the individual susceptible to infections and covid 19 is no exception . Also covid 19 can cause pancreatic damage as well as stress hyperglycaemia in hospitals which may need Insulin . Among diabetes male gender,elderly,hypertension ,heart disease and chronic renal disease are more vulbwdvale to covid 19 and need strict supervision . Diabetes management in hospitalised situation merits early diabetes specific nutrition with Insulin. Adherence to lifestyle with self monitoring of blood glucose and adequate supply of Insulin and Oral antidiabetic agents is encouraged.

MeSH terms

  • Betacoronavirus
  • Blood Glucose / analysis
  • COVID-19
  • Coronavirus Infections / complications*
  • Diabetes Mellitus, Type 2 / complications*
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Obesity / complications*
  • Pandemics
  • Pneumonia, Viral / complications*
  • Risk Factors
  • SARS-CoV-2

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin